# Diagnosia Internet Services

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/diagnosia-internet-services

- Industry: Internet
- Headquarters: Vienna, Austria
- Website: www.diagnosia.com
- Latest round: Seed (Apr 5, 2017)
- Investors on record: 1

## About

Diagnosia Internet Services GmbH is a specialized provider of medical applications for healthcare professionals, delivering essential drug information and education through innovative digital solutions.Diagnosia Internet Services GmbH, founded in 2011, is headquartered in Vienna, Austria. The company focuses on creating a comprehensive medical application tailored for healthcare providers. Eric Pfarl and Lukas Zinnagl are the founders, with Lukas Zinnagl currently serving as CEO. In November 2019, Diagnosia raised EUR 1.00 mn in an Angel funding round led by the Austrian Research Promotion Agency, totaling EUR 1.00 mn in funding since inception. The firm has successfully completed four deals.Diagnosia specializes in providing a comprehensive medical application designed for healthcare professionals, particularly physicians. The app offers rapid access to essential information regarding medications, including dosage, equivalent preparations, and reimbursement details, crucial for clinical settings. Integrated features such as a barcode scanner facilitate quick medication identification, while an extensive database provides current and evidence-based drug information, including potential drug interactions and their clinical significance. Additionally, the app includes in-app educational resources, such as podcasts featuring expert discussions and a dedicated platform for continuing medical education called 'Diagnosia Campus.' The primary users of Diagnosia's services are healthcare providers, particularly in German-speaking markets, including Austria, Germany, and Switzerland.Diagnosia's revenue model is rooted in subscriptions and partnerships with healthcare organizations and educational institutions. The app offers tiered pricing plans catering to individual practitioners as well as larger medical facilities. Transactions typically occur through direct subscriptions to the app, which may include access to premium features such as advanced drug interaction data and specialized educational content. By engaging directly with healthcare professionals and institutions, Diagnosia creates a streamlined channel for revenue generation, enhancing their market presence while ensuring that users have access to vital medication information and continuing education resources.Looking forward, Diagnosia aims to expand its product offerings and enhance its application features. The company is currently designing new tools that will further support healthcare providers, with expected launches in the near future. Additionally, Diagnosia is targeting expansion into new markets within Europe, aiming to strengthen its presence in Germany and Switzerland by the end of 2021. The funds raised from the Angel round will be utilized to enhance product development and facilitate market entry strategies.

## Funding rounds

- Seed, Apr 5, 2017 — Speedinvest

## Investors

- Speedinvest (https://capitalatlas.ai/funds/speedinvest) — Seed